Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,941 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07420985RecruitingPhase 2
Ingavirin forte for flu and other viral infections
This trial tests different doses of Ingavirin Forte capsules for treating influenza and other respiratory viruses. It may help people with fever, cough, sore throat, and body aches who have been sick less than 48 hours.
IvanovoAges 18–65 - NCT07421297RecruitingPhase 3
Study of SYH2053 for high cholesterol in Chinese adults
This trial tests a new medication called SYH2053 for people with high cholesterol or mixed high cholesterol and triglycerides. If you have high LDL cholesterol and are not taking strong cholesterol medicines, you may be able to join. The study will see if this drug is safe and works well.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07422207RecruitingPhase 1
Safety study of ME3241 in healthy adults
This trial is testing a new intravenous medicine (ME3241) for safety and how the body handles it. It's for healthy adults, so researchers can see how the drug works before testing it in people with the target condition.
Sydney, New South WalesAges 18–55 - NCT07423533RecruitingPhase 2
GenSci120 injection for moderate to severe rheumatoid arthritis
This trial tests a new injection called GenSci120 for people with moderate to severe rheumatoid arthritis who haven't improved enough after trying at least one standard arthritis medication. The goal is to see if this treatment can help reduce joint pain and swelling.
Beijing, Beijing MunicipalityAges 18–70 - NCT07425938Recruiting
How oxytocin affects emotional processing
This study looks at how oxytocin, a natural hormone, influences the way we process emotions. Healthy volunteers will receive oxytocin to understand its effects on emotion and brain activity.
Chengdu, SichuanAges 18–30 - NCT07429006RecruitingPhase 1
First human trial of AKB-9090 in healthy adults
This study is testing a new medication called AKB-9090 for the first time in people. It will help find out how the drug works in the body and how safe it is. The study is looking for healthy volunteers.
AucklandAges 18–60 - NCT07429448RecruitingPhase 1
Numbing medicine for pain after appendix removal
This trial tests whether numbing medicine (bupivacaine) placed into the belly during an open appendix removal helps reduce pain after surgery, compared to a placebo (a shot with no medicine).
Lahore, Punjab ProvinceAges 20–60 - NCT07430956RecruitingPhase 3
Stroke prevention in atrial fibrillation without standard blood thinners
This trial tests a new medication to prevent strokes and blood clots in people with atrial fibrillation (an irregular heartbeat) who cannot safely take standard blood thinners. The drug works by blocking a different clotting factor, which may lower bleeding risks.
Dothan, AlabamaAges 18 years+ - NCT07431840Recruiting
Immune protein for respiratory infections in older adults
This trial tests whether an immune defense protein can help reduce upper respiratory infections (like colds) in people aged 60 and older. It may be a good fit if you get colds or flu-like symptoms several times each season.
Los Angeles, CaliforniaAges 60 years+ - NCT07432399RecruitingPhase 2
Lidocaine or dexamethasone before colon cancer surgery
This study tests whether giving lidocaine or a high-dose steroid before colon cancer surgery can improve immune function and recovery. The goal is to find a simple, safe way to help your body respond better during surgery.
LjubljanaAges 18 years+ - NCT07433179RecruitingPhase 1
Testing SEP-479 in healthy adults
This trial tests a new medication called SEP-479 in healthy volunteers to see how the body handles it. Volunteers receive either a single dose or multiple doses of the drug as part of early safety research.
MelbourneAges 21–60 - NCT07433023RecruitingPhase 2
Spinal stimulation and drug therapy for motor skills in cerebral palsy
This trial tests if combining spinal cord stimulation with a drug called 5-azacitidine can improve movement and muscle control in children with cerebral palsy. It aims to help with daily activities like walking or using hands.
Chicago, IllinoisAges 4–17 - NCT07433426RecruitingPhase 2
Shigella infection treatment study for young children
This study tests how well a recommended treatment works for children aged 6 months to 5 years who have diarrhea caused by Shigella bacteria. It aims to find the best way to help children recover faster.
ChāndpurAges 6 months–4.9 years - NCT07433556RecruitingPhase 1
Testing a new stomach acid drug in healthy adults
This phase 1 trial tests a new medicine called IY-828026 in healthy volunteers to see how safe it is and how the body processes it. It's a first step to find the right dose and check for side effects.
SeoulAges 19–50 - NCT07434050RecruitingPhase 3
Study of XW003 for obesity with sleep apnea on CPAP therapy
This trial tests an investigational drug called XW003 to see if it helps people with obesity and obstructive sleep apnea who are already using a positive airway pressure (PAP) machine, like CPAP. It aims to improve weight loss and sleep apnea symptoms.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07434492RecruitingPhase 2
Smart ankle brace and medicine to help kids with cerebral palsy walk better
This trial tests whether a smart ankle brace combined with a medicine called 5-azacitidine can improve walking ability in children with cerebral palsy. The study compares the medicine to a placebo to see if it helps enhance mobility.
Chicago, IllinoisAges 8–17 - NCT07434752RecruitingPhase 4
Energy drink with caffeine and green tea for fat burning during exercise
This study tests whether an energy drink containing caffeine and green tea extract helps increase fat burning while you exercise. Researchers want to see if it can boost your metabolism during physical activity.
Southport, QueenslandAges 18–45 - NCT07435012RecruitingPhase 3
Hair loss treatment trial for men ages 18 to 49
This trial tests a new treatment for male pattern baldness (androgenic alopecia). It is for men with a moderate level of hair loss who have not used any hair loss treatments in the last 90 days.
Vancouver, British ColumbiaAges 18–49 - NCT07437105RecruitingPhase 1
Healthy volunteer study of VX-272 safety
This study tests a new investigational medicine called VX-272 in healthy volunteers. Researchers want to check its safety and how it moves through the body, so you would not have the condition the medicine is being developed for.
Tempe, ArizonaAges 18–55 - NCT07437430Recruiting
Study on food additives and weight in adults with obesity
This study looks at how certain food additives might affect weight. If you have obesity, you may be able to join to help understand how these additives play a role.
Hamilton, OntarioAges 20–80 - NCT07437547RecruitingPhase 2
BPC 157 for acute hamstring muscle repair
This study tests whether an investigational peptide called BPC 157 can help heal a grade II hamstring strain (a pulled muscle) faster and more completely. If you have a recent hamstring injury and are active in sports or exercise, this trial may be an option.
Shenzhen, GuangdongAges 18–45 - NCT07437560RecruitingPhase 2
Melanotan II plus light therapy for vitiligo repigmentation
This trial tests whether adding a daily nasal spray (Melanotan II) to light therapy helps restore color in stable vitiligo patches. It may be a good option for adults with mild to moderate nonsegmental vitiligo that hasn't changed in at least 6 months.
Shenzhen, GuangdongAges 18–65 - NCT07439263RecruitingPhase 1
First test of HB2198 in healthy adults
This study tests a single dose of an experimental therapy (HB2198) in healthy volunteers to see how the body handles it. It is a first-in-human trial designed to check safety and how the drug affects your immune system.
Bayswater, VictoriaAges Up to 55 years - NCT07440069RecruitingPhase 4
Pain relief options for women during active labor
This trial compares the pain relief and effects of tramadol, paracetamol (also known as acetaminophen), and a placebo in women during active labor. It aims to find which option works best and is safest for mothers and babies.
Tegucigalpa, Francisco Morazán DepartmentAges 15–45
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,941 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.